Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiographic Image Enhancement | 15 | 2010 | 27 | 2.940 |
Why?
|
| Cartilage, Articular | 17 | 2011 | 413 | 2.380 |
Why?
|
| X-Ray Diffraction | 10 | 2010 | 13 | 1.990 |
Why?
|
| Ankle Joint | 6 | 2010 | 43 | 1.020 |
Why?
|
| Foot | 5 | 2010 | 37 | 1.000 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 5 | 2010 | 29 | 0.990 |
Why?
|
| Talus | 5 | 2010 | 16 | 0.950 |
Why?
|
| Tendons | 5 | 2009 | 218 | 0.710 |
Why?
|
| Intervertebral Disc | 10 | 2018 | 127 | 0.650 |
Why?
|
| Cartilage | 3 | 2009 | 104 | 0.650 |
Why?
|
| Ankle | 3 | 2010 | 21 | 0.640 |
Why?
|
| Connective Tissue | 3 | 2009 | 21 | 0.630 |
Why?
|
| Osteoarthritis | 4 | 2010 | 316 | 0.630 |
Why?
|
| Arthrography | 4 | 2006 | 28 | 0.540 |
Why?
|
| Bone and Bones | 3 | 2004 | 110 | 0.500 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2007 | 75 | 0.400 |
Why?
|
| Rabbits | 11 | 2018 | 180 | 0.370 |
Why?
|
| Chondrocytes | 2 | 2009 | 148 | 0.360 |
Why?
|
| Knee | 1 | 2010 | 43 | 0.350 |
Why?
|
| Tissue Donors | 1 | 2010 | 72 | 0.340 |
Why?
|
| Radiography | 7 | 2014 | 616 | 0.330 |
Why?
|
| Etidronic Acid | 1 | 2009 | 4 | 0.330 |
Why?
|
| Achilles Tendon | 1 | 2009 | 15 | 0.320 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 15 | 0.320 |
Why?
|
| Foot Bones | 1 | 2008 | 1 | 0.320 |
Why?
|
| Animals | 16 | 2018 | 3391 | 0.320 |
Why?
|
| Bone Resorption | 1 | 2009 | 83 | 0.310 |
Why?
|
| Ossification, Heterotopic | 1 | 2008 | 36 | 0.310 |
Why?
|
| Chondrocalcinosis | 1 | 2008 | 4 | 0.310 |
Why?
|
| Refractometry | 2 | 2008 | 2 | 0.310 |
Why?
|
| Uric Acid | 1 | 2008 | 13 | 0.300 |
Why?
|
| Humans | 27 | 2014 | 26260 | 0.300 |
Why?
|
| Intervertebral Disc Degeneration | 3 | 2018 | 85 | 0.290 |
Why?
|
| Joint Capsule | 1 | 2007 | 46 | 0.270 |
Why?
|
| Tendon Injuries | 1 | 2009 | 206 | 0.260 |
Why?
|
| Osteoarthritis, Knee | 3 | 2010 | 359 | 0.260 |
Why?
|
| Knee Joint | 4 | 2010 | 758 | 0.260 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 92 | 0.260 |
Why?
|
| Elbow Joint | 1 | 2007 | 125 | 0.250 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 485 | 0.230 |
Why?
|
| Reproducibility of Results | 7 | 2009 | 677 | 0.220 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 570 | 0.220 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 79 | 0.220 |
Why?
|
| Femur Head | 1 | 2004 | 60 | 0.220 |
Why?
|
| Cartilage Diseases | 1 | 2005 | 95 | 0.220 |
Why?
|
| Cadaver | 4 | 2009 | 370 | 0.220 |
Why?
|
| Musculoskeletal System | 1 | 2003 | 7 | 0.220 |
Why?
|
| Metatarsal Bones | 1 | 2003 | 8 | 0.220 |
Why?
|
| Middle Aged | 11 | 2014 | 8600 | 0.210 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 1 | 0.210 |
Why?
|
| Activin Receptors, Type II | 1 | 2002 | 1 | 0.210 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 3 | 0.210 |
Why?
|
| Adipose Tissue | 1 | 2003 | 62 | 0.210 |
Why?
|
| Proteoglycans | 4 | 2007 | 130 | 0.200 |
Why?
|
| Algorithms | 2 | 2008 | 363 | 0.200 |
Why?
|
| Proteins | 1 | 2002 | 54 | 0.200 |
Why?
|
| Male | 12 | 2014 | 14124 | 0.190 |
Why?
|
| Intervertebral Disc Displacement | 3 | 2006 | 86 | 0.180 |
Why?
|
| Spinal Diseases | 3 | 2007 | 114 | 0.180 |
Why?
|
| X-Ray Intensifying Screens | 2 | 2010 | 2 | 0.170 |
Why?
|
| Female | 10 | 2018 | 14516 | 0.170 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 337 | 0.170 |
Why?
|
| Aged | 8 | 2014 | 8764 | 0.160 |
Why?
|
| Adult | 6 | 2011 | 7447 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2011 | 4675 | 0.160 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hyperalgesia | 1 | 2018 | 36 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2014 | 6 | 0.150 |
Why?
|
| Radiculopathy | 1 | 2018 | 46 | 0.140 |
Why?
|
| Lumbar Vertebrae | 4 | 2014 | 411 | 0.140 |
Why?
|
| Cicatrix | 2 | 2006 | 8 | 0.130 |
Why?
|
| Sex Factors | 2 | 2010 | 450 | 0.130 |
Why?
|
| Scattering, Radiation | 2 | 2006 | 36 | 0.120 |
Why?
|
| Anatomy, Comparative | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mammals | 1 | 2014 | 22 | 0.110 |
Why?
|
| Adolescent | 3 | 2011 | 2079 | 0.110 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 36 | 0.110 |
Why?
|
| Spine | 1 | 2014 | 111 | 0.100 |
Why?
|
| Equipment Design | 2 | 2009 | 144 | 0.100 |
Why?
|
| Prevalence | 2 | 2011 | 437 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 226 | 0.100 |
Why?
|
| Thumb | 2 | 2014 | 6 | 0.090 |
Why?
|
| Collagen | 3 | 2010 | 81 | 0.090 |
Why?
|
| Glycosaminoglycans | 1 | 2010 | 20 | 0.090 |
Why?
|
| Zygapophyseal Joint | 1 | 2011 | 32 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2010 | 65 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 7 | 3 | 2007 | 33 | 0.090 |
Why?
|
| Calcinosis | 1 | 2010 | 47 | 0.090 |
Why?
|
| Body Weight | 1 | 2010 | 121 | 0.090 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2009 | 5 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 68 | 0.080 |
Why?
|
| ADAM Proteins | 1 | 2009 | 39 | 0.080 |
Why?
|
| Swine, Miniature | 1 | 2009 | 3 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2009 | 18 | 0.080 |
Why?
|
| Dogs | 2 | 2006 | 176 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2009 | 18 | 0.080 |
Why?
|
| Swine | 1 | 2009 | 65 | 0.080 |
Why?
|
| South Africa | 1 | 2008 | 11 | 0.080 |
Why?
|
| Tomography, X-Ray | 1 | 2008 | 2 | 0.080 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 8 | 0.080 |
Why?
|
| Ankle Injuries | 1 | 2008 | 9 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2010 | 936 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 751 | 0.070 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 287 | 0.070 |
Why?
|
| Cattle | 4 | 2010 | 117 | 0.070 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2007 | 4 | 0.070 |
Why?
|
| Phantoms, Imaging | 2 | 2006 | 36 | 0.070 |
Why?
|
| Intervertebral Disc Chemolysis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Collagen Type III | 1 | 2007 | 12 | 0.070 |
Why?
|
| Metalloproteases | 1 | 2007 | 7 | 0.070 |
Why?
|
| Antigens | 1 | 2007 | 7 | 0.070 |
Why?
|
| Contracture | 1 | 2007 | 13 | 0.070 |
Why?
|
| Metals | 1 | 2008 | 142 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2006 | 13 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 159 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 1157 | 0.070 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2006 | 4 | 0.070 |
Why?
|
| Thrombin | 1 | 2006 | 11 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 12 | 0.070 |
Why?
|
| Gait | 1 | 2010 | 408 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 10 | 0.070 |
Why?
|
| Incidence | 1 | 2008 | 716 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 102 | 0.070 |
Why?
|
| Models, Animal | 1 | 2006 | 106 | 0.070 |
Why?
|
| Laminectomy | 1 | 2006 | 43 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2007 | 474 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 853 | 0.060 |
Why?
|
| Observer Variation | 1 | 2005 | 93 | 0.060 |
Why?
|
| Ligaments, Articular | 1 | 2006 | 106 | 0.060 |
Why?
|
| Rats | 2 | 2018 | 596 | 0.060 |
Why?
|
| Arthritis | 1 | 2004 | 52 | 0.060 |
Why?
|
| Phenazines | 1 | 2004 | 3 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2004 | 12 | 0.060 |
Why?
|
| Punctures | 2 | 2018 | 10 | 0.060 |
Why?
|
| Hallux | 1 | 2003 | 2 | 0.050 |
Why?
|
| Ligaments | 1 | 2003 | 15 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 459 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2002 | 1 | 0.050 |
Why?
|
| Keratan Sulfate | 1 | 2002 | 15 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 18 | 0.050 |
Why?
|
| Biomechanical Phenomena | 3 | 2010 | 639 | 0.050 |
Why?
|
| Menisci, Tibial | 1 | 2004 | 177 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 723 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 187 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 217 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 47 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 119 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 13 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 12 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2018 | 25 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 23 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 66 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 44 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 85 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 30 | 0.030 |
Why?
|
| Injections, Spinal | 2 | 2007 | 32 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 315 | 0.030 |
Why?
|
| X-Rays | 1 | 2014 | 5 | 0.030 |
Why?
|
| Goats | 1 | 2014 | 7 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 41 | 0.030 |
Why?
|
| Growth Plate | 1 | 2014 | 14 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2014 | 77 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 318 | 0.030 |
Why?
|
| Time Factors | 2 | 2007 | 1382 | 0.030 |
Why?
|
| Osteophyte | 1 | 2011 | 7 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 7 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 2010 | 23 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 55 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 163 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 1282 | 0.020 |
Why?
|
| Joint Diseases | 1 | 2011 | 108 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 104 | 0.020 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 15 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 101 | 0.020 |
Why?
|
| Receptor, trkA | 1 | 2007 | 7 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 9 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 53 | 0.020 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Cell Communication | 1 | 2007 | 23 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 200 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2006 | 8 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 184 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 58 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 210 | 0.020 |
Why?
|
| DNA | 1 | 2006 | 93 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 151 | 0.020 |
Why?
|
| Photons | 1 | 2006 | 4 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2007 | 264 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 186 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 236 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1738 | 0.020 |
Why?
|
| Wounds, Stab | 1 | 2005 | 2 | 0.020 |
Why?
|
| United States | 1 | 2011 | 1989 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 1886 | 0.020 |
Why?
|
| Needles | 1 | 2005 | 20 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2003 | 15 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 1538 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 868 | 0.010 |
Why?
|